688091.SS
688091.SS
CNE1000050F4
SHANGHAI YIZHONG PHARMACEUTICAL
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 316.076.818 173.532.721
82.1%
Cost of Revenue 53.367.631 13.332.457
300.3%
Gross Profit 262.709.187 160.200.264
64.0%
212.750.137 179.961.082
18.2%
Operating Income 49.959.049 -19.760.818
352.8%
Pretax Income 61.149.325 4.817.201
1169.4%
Net Income Common Stockholders 64.555.772 6.975.283
825.5%
-- --
--
-- --
--
ende